Koninklijke Philips | PHG - Operating Expenses


Koninklijke Philips reported EUR5.1B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
Demant DKK 9.63B 241M Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Fresenius EUR 5.25B 337M Dec/2025
General Electric Aerospace USD 18.06B 7.11B Mar/2026
Getinge SEK 9.99B 2.3B Dec/2024
Globus Medical USD 645.11M 241.46M Dec/2025
GN Store Nord DKK 4.11B 490M Dec/2025
Hitachi JPY 2.4T 164.67B Dec/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
Intuitive Surgical USD 1.91B 89.8M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Koninklijke Philips EUR 5.1B 597.33M Dec/2025
Masimo USD 328.6M 181.6M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Philips EUR 4.38B 405M Dec/2025
ResMed USD 925.21M 51.98M Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025
Steris USD 1.22B 28.8M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025